TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07212660: A Multi-center, Randomized-controlled, 12-month, Split-mouth, Non-inferiority Clinical Trial to Compare the Safety and Performance of Two Different Curing Modes in the Direct Filling Therapy With a Flowable Bulk Fill Com

Sponsor: Ivoclar Vivadent AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 70 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,557,600

Rescue Site Savings

+$6,972,000

Unlock Full NCT07212660 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07212660 Rescue Dossier →